Literature DB >> 8892013

Molecular genetics of methylenetetrahydrofolate reductase deficiency.

R Rozen1.   

Abstract

In severe MTHFR deficiency with neonatal or adolescent onset, 9 rare mutations have been identified. In mild MTHFR deficiency with thermolabile enzyme, a single common mutation (an alanine-to-valine substitution) is involved, but a genetic-nutrient interactive effect is required to produce mild hyperhomocysteinaemia. This interactive effect has been proposed to be a risk factor for arteriosclerosis and for neural-tube defects. Large-scale studies are required for confirmation of the role of MTHFR in these multifactorial processes as well as to assess its role in other folate-dependent disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892013     DOI: 10.1007/bf01799831

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  19 in total

Review 1.  Homocyst(e)ine and arterial occlusive diseases.

Authors:  M R Malinow
Journal:  J Intern Med       Date:  1994-12       Impact factor: 8.989

2.  Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.

Authors:  B Christensen; P Frosst; S Lussier-Cacan; J Selhub; P Goyette; D S Rosenblatt; J Genest; R Rozen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-03       Impact factor: 8.311

Review 3.  Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid.

Authors:  A G Motulsky
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

4.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

5.  Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency.

Authors:  P Goyette; P Frosst; D S Rosenblatt; R Rozen
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

6.  Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia.

Authors:  A M Engbersen; D G Franken; G H Boers; E M Stevens; F J Trijbels; H J Blom
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

7.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

8.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

Authors:  P F Jacques; A G Bostom; R R Williams; R C Ellison; J H Eckfeldt; I H Rosenberg; J Selhub; R Rozen
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

9.  Homocysteine metabolism in pregnancies complicated by neural-tube defects.

Authors:  J L Mills; J M McPartlin; P N Kirke; Y J Lee; M R Conley; D G Weir; J M Scott
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321

10.  Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease.

Authors:  S S Kang; P W Wong; A Susmano; J Sora; M Norusis; N Ruggie
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

View more
  35 in total

1.  Methylenetetrahydrofolate reductase 677C > T mutation and epilepsy.

Authors:  H Ono; A Sakamoto; N Mizoguchi; N Sakura
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

2.  Polymorphisms of MTHFR C677T and A1298C associated with survival in patients with colorectal cancer treated with 5-fluorouracil-based chemotherapy.

Authors:  Chih-Ching Yeh; Ching-Yu Lai; Shih-Ni Chang; Ling-Ling Hsieh; Reiping Tang; Fung-Chang Sung; Yi-Kuei Lin
Journal:  Int J Clin Oncol       Date:  2017-01-02       Impact factor: 3.402

Review 3.  Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?

Authors:  P Ranganathan; S Eisen; W M Yokoyama; H L McLeod
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

4.  Ethnogeographic prevalence and implications of the 677C>T and 1298A>C MTHFR polymorphisms in US primary care populations.

Authors:  James S Graydon; Karla Claudio; Seth Baker; Mohan Kocherla; Mark Ferreira; Abiel Roche-Lima; Jovaniel Rodríguez-Maldonado; Jorge Duconge; Gualberto Ruaño
Journal:  Biomark Med       Date:  2019-06-03       Impact factor: 2.851

5.  Associations of the MTHFR rs1801133 polymorphism with gastric cancer risk in the Chinese Han population.

Authors:  Zhiqiang Han; Huaming Sheng; Qiuzhi Gao; Yu Fan; Xiang Xie
Journal:  Biomed Rep       Date:  2020-11-17

6.  Homocysteine-induced cardiomyocyte apoptosis and plasma membrane flip-flop are independent of S-adenosylhomocysteine: a crucial role for nuclear p47(phox).

Authors:  Jessica A Sipkens; Paul A J Krijnen; Nynke E Hahn; Melissa Wassink; Christof Meischl; Desirée E C Smith; René J P Musters; Coen D A Stehouwer; Jan A Rauwerda; Victor W M van Hinsbergh; Hans W M Niessen
Journal:  Mol Cell Biochem       Date:  2011-07-08       Impact factor: 3.396

Review 7.  Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?

Authors:  Heinrike Schmeling; Gerd Horneff; Susanne M Benseler; Marvin J Fritzler
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

8.  Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).

Authors:  Maple M Fung; Rany M Salem; Michael S Lipkowitz; Vibha Bhatnagar; Braj Pandey; Nicholas J Schork; Daniel T O'Connor
Journal:  Nephrol Dial Transplant       Date:  2011-05-25       Impact factor: 5.992

9.  Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.

Authors:  Marie-Christine Etienne-Grimaldi; Gérard Milano; Frédérique Maindrault-Goebel; Benoist Chibaudel; Jean-Louis Formento; Mireille Francoual; Gérard Lledo; Thierry André; May Mabro; Laurent Mineur; Michel Flesch; Elisabeth Carola; Aimery de Gramont
Journal:  Br J Clin Pharmacol       Date:  2010-01       Impact factor: 4.335

Review 10.  MTHFR: Addressing Genetic Counseling Dilemmas Using Evidence-Based Literature.

Authors:  Brooke Levenseller Levin; Elizabeth Varga
Journal:  J Genet Couns       Date:  2016-04-30       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.